Girao Tiago 4
4 · Immunovant, Inc. · Filed Apr 24, 2026
Research Summary
AI-generated summary of this filing
Immunovant (IMVT) CFO Tiago Girao Sells 25,760 Shares
What Happened
Tiago Girao, Chief Financial Officer of Immunovant, sold 25,760 shares (reported as a sale) on April 23, 2026, for a weighted-average price of $29.62 per share, generating proceeds of approximately $763,011. This was a sell-to-cover transaction tied to the vesting and settlement of previously granted RSUs and not a discretionary open-market sale.
Key Details
- Transaction date: 2026-04-23; Form 4 filed: 2026-04-24 (timely filing).
- Shares sold: 25,760; weighted-average price: $29.62; total proceeds: ~$763,011.
- Price range: $29.23–$30.00 per share (sale occurred in multiple trades; reporting person will provide per-price breakdown upon request).
- Shares owned after transaction: Not specified in the filing.
- Footnote: On May 1, 2025 the reporting person was granted 208,388 RSUs; 52,097 vested on April 21, 2026. The sale was mandated by the issuer’s sell-to-cover election to satisfy tax withholding and was not a discretionary sale by the reporting person.
Context
Sell-to-cover transactions are a common, administrative step when restricted stock units vest and taxes are due; they generally reflect tax withholding needs rather than a judgment about the company's prospects.
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Girao Tiago
Chief Financial Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-04-23$29.62/sh−25,760$763,011→ 247,596 total
Footnotes (2)
- [F1]On May 1, 2025, the holder was granted 208,388 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on May 5, 2025, of which 52,097 of these RSUs vested on April 21, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.23 - $30.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Signature
/s/ Tiago Girao|2026-04-24